ANAB Earnings

Quarterly EPS
$-1.71
Q2 2024
$-1.14
Q3 2024
$-0.71
Q4 2024
$-1.28
Q1 2025
$-1.34
Q2 2025
$0.54
Q3 2025
$1.79
Q4 2025
$-1.84
Q1 2026
Latest Revenue25.6M
Latest Net Income-52884000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$1.8425.6M-52884000-8.0%-43.8%
Q4 2025$1.79108.2M49.6M+151.1%+352.1%
Q3 2025$0.5476.3M15.1M+154.3%+147.4%
Q2 2025-$1.3422.3M-38630000+102.9%+21.6%
Q1 2025-$1.2827.8M-39329000+286.8%+22.0%
Q4 2024-$0.7143.1M-21784000+378.8%+55.3%
Q3 2024-$1.1430.0M-32851000+804.7%+19.1%
Q2 2024-$1.7111.0M-46660000+217.1%-14.0%
Q1 2024-$1.647.2M-43936000
Q4 2023-$1.599.0M-42211000
Q3 2023-$1.413.3M-37308000
Q2 2023-$1.503.5M-39845000
AnaptysBio (ANAB) — Earnings